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Summary 
The molecular mechanism underlying G1/S checkpoint bypass in mouse embryonic 
stem (ES) cells remains unknown. DNA damage blocks S-phase entry by inhibiting 
the CDK2 kinase through destruction of its activator, the Cdc25A phosphatase. We 
observed high Cdc25A levels in G1 that persist even after DNA damage in mouse ES 
cells. We also found higher expression of Dub3, a deubiquitylase that controls 
Cdc25A protein abundance. Moreover, we demonstrate that the Dub3 gene is a 
direct target of Esrrb, a key transcription factor of the self-renewal machinery. We 
show that Dub3 expression is strongly downregulated during neural conversion and 
precedes Cdc25A destabilization, while forced Dub3 expression in ES cells becomes 
lethal upon differentiation, concomitant to cell cycle remodelling and lineage 
commitment. Finally, knockdown of either Dub3 or Cdc25A induced spontaneous 
differentiation of ES cells. Altogether, these findings couple the self-renewal 
machinery to cell cycle control through a deubiquitylase in ES cells. 
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Highlights (85 character per point) 
 
 Cdc25A persistence upon DNA damage sustains G1/S checkpoint bypass in ES 
cells 
 Dub3 is rapidly downregulated during neural conversion and Cdc25A is 
destabilized 
 Dub3 is a target of Esrrb, a key transcription factor of the self-renewal machinery 
 Dub3 or Cdc25A knockdown induces heterogeneous differentiation in the 
presence of LIF 
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Introduction 
Eukaryotic cells have developed checkpoints to block cell cycle progression upon 
DNA damage or replication stress (Ciccia and Elledge, 2010). Two distinct pathways 
pertain to the G1/S checkpoint by directly reducing CDK2 activity: a) rapid destruction 
of the Cdc25A phosphatase resulting in increased CDK2 phosphorylation (Mailand et 
al., 2000; Sexl et al., 1999), and b) a slower, p53-mediated, transcriptional response 
that activates expression of, amongst others, the potent CDK2 inhibitor p21 
(Brugarolas et al., 1995; Dulic et al., 1994). Importantly, rapid p21 degradation 
observed after exposure to low UV doses may be important for optimal DNA repair 
(Bendjennat et al., 2003; Chen et al., 2004; Lee et al., 2006), while inhibition of CDK2 
activity following Cdc25A degradation is sufficient for cell cycle arrest (Bendjennat et 
al., 2003). Cdc25A protein levels are tightly regulated by two E3 ubiquitin ligases, the 
Anaphase Promoting Complex/Cyclosome (APC/CCdh1) as cells exit mitosis, and the 
Skp1-Cullin1-Fbox (SCFTrCP) during both S and G2 phase and following DNA 
damage (Busino et al., 2003; Donzelli et al., 2002).  
Compared to somatic cells, mouse embryonic stem (ES) cells appear to have 
a relaxed G1/S checkpoint (Aladjem et al., 1998; Hong and Stambrook, 2004; 
Koledova et al., 2010; Prost et al., 1998). The molecular mechanism underlying this 
feature remains unclear. Moreover, mouse ES cell cycle has remarkably short G1 
and G2 phases, with little S phase length variation (Ballabeni et al., 2011; Savatier et 
al., 2002; White et al., 2005). This is underpinned by high CDK2/Cyclin E activity 
(Stead et al., 2002) and reduced APC/C activity leading to limited oscillation in 
substrate levels (Ballabeni et al., 2011). Interestingly, knockdown of CDK2 protein 
was shown to increase G1 length although DNA damage-dependent degradation of 
Cdc25A was reported not to affect CDK2 activity, nor to induce a G1 arrest 
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(Koledova et al., 2010; Neganova et al., 2011; Neganova et al., 2009). In contrast, a 
previous study reported that Cdc25A is not degraded upon -irradiation in ES cells 
(Hong and Stambrook, 2004). 
 Maintenance of pluripotency depends upon expression of pluripotency genes 
under the combinatorial control of a regulatory network of transcription factors such 
as Nanog, Sox2 and Oct4 (Festuccia et al., 2013; van den Berg et al., 2008). 
Differentiation of ES cell induces cell cycle remodelling, including appearance of 
longer G1 and G2 phases, but how this regulation is achieved is unknown. Moreover, 
how the pluripotency regulatory network impacts onto cell cycle control remains 
obscure. Aside from its well-known role in somatic cell cycle, very little is known 
about Cdc25A function in ES cells. In human ES cells, Cdc25A expression was 
shown to be regulated by Nanog (Zhang et al., 2009). A recent report shows that 
Nanog knockdown in mouse ES cells results in G1/S transition delay by an unknown 
mechanism (Chen et al., 2012). Equally, the role of p53 in ES cells G1/S DNA 
damage checkpoint still remains controversial (Aladjem et al., 1998; Sabapathy et al., 
1997; Solozobova et al., 2009). Despite its high abundance, p53 has been proposed 
to be inactive in ES cells due to a predominant cytoplasmic distribution (Solozobova 
et al., 2009). 
In this study we sought to understand the molecular grounds for inefficient 
G1/S DNA damage checkpoint in ES cells. We found that high Cdc25A abundance 
sustains G1/S checkpoint bypass in ES cells. We show that Cdc25A abundance 
depends upon high expression of Dub3, a deubiquitylase that fine-tunes Cdc25A 
steady-state levels (Pereg et al., 2010). Moreover, we identify Dub3 as a novel target 
gene of estrogen-related-receptor-b (Esrrb), a key transcription factor of the self-
renewal machinery (Festuccia et al., 2012; Ivanova et al., 2006; Martello et al., 2012). 
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Strikingly, we observed acute downregulation of Dub3 expression upon differentiation 
and its knockdown induced spontaneous ES cell differentiation. In sum, our data 
interconnect the self-renewal machinery to cell cycle control and highlight the 
importance of deubiquitylases in stem cell and developmental biology.  
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Results 
ES cells arrest in early S phase upon induction of DNA damage in G1 
Circumstantial data suggest an impaired G1/S checkpoint in ES cells (Hong and 
Stambrook, 2004; Koledova et al., 2010; Aladjem et al., 1998; Prost et al., 1998). We 
observed that irradiation of ES cells with increasing doses of UV light induced a 
decrease in the number of G1 cells (Figure S1A). Time course analysis with a single 
UV dose (6 J/m2) resulted in cell cycle delay at the G1/S boundary (Figure S1B, t=2). 
We pulse-labelled nocodazole synchronized cells with BrdU (a nucleotide analogue) 
to allow exact distinction between late G1 (BrdU-negative) and early S-phase (BrdU-
positive, Figure 1A). While analysis of total DNA content suggests a G1 arrest 
(Figure 1B), analysis of BrdU incorporation revealed that both untreated (Mock) and 
UV-irradiated cells (+ UV) entered S phase with very similar kinetics (Figure 1C-D). In 
contrast, synchronized mouse embryonic fibroblasts (NIH-3t3), which are Oct4-
negative differentiated cells (Figure S1C), did not progress to S phase after UV 
irradiation in G1 (Figure 1E), in line with the presence of a stringent G1/S checkpoint.  
We noticed that upon UV irradiation, BrdU incorporation was slightly reduced 
compared to mock-irradiated cells, confirmed by calculating the mean fluorescent 
signal of BrdU-positive cells (Figure 1E, green boxes), and suggesting DNA 
synthesis slowdown in very early S phase. Analysis of chromatin-bound proteins 
shows that recruitment of both Cdc45 and DNA polymerase-two replication fork-
associated factors, was considerably reduced upon UV irradiation, but not abolished 
(Figure S1D, compare lanes 2-4 with 5-7), suggesting activation of the S phase 
checkpoint preventing late replication origins firing (Karnani and Dutta, 2011). 
Consistent with this possibility, phosphorylated H2AX histone variant (H2AX), an 
ATR substrate, accumulated onto chromatin. Moreover UV-induced DNA damage did 
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not significantly change the transcriptional program driven by E2F transcription 
factors required for S phase entry, as monitored by Cyclin A2 and E1 production 
(Figure S1E). We also observed UV damage-dependent p53 phosphorylation on 
chromatin (Figure S2A), and transactivation (amongst other) of p21 gene expression 
(Figure S2B-D), demonstrating a functional p53 transcriptional response, in line with 
a previous study (Solozobova et al., 2009).  
 
Persistent high levels of Cdc25A in ES cells sustain G1/S checkpoint bypass 
Cdc25A functions as a critical CDK2 regulator by removing an inhibitory 
phosphorylation on Tyrosine 15 (CDK2Y15P) that in turn regulates S phase 
progression. We compared Cdc25A and CDK2 protein abundance between ES cells 
and NIH-3t3 cells (Figure 2A). Strikingly, while CDK2 abundance is marginally higher 
in ES cells, the levels of Cdc25A in asynchronously growing ES cells are exceedingly 
high compared to NIH-3t3 cells. As expected, upon UV-induced DNA damage, 
Cdc25A was degraded in both cell lines (Figure 2A). However, one hour after 
irradiation, Cdc25A level remained about 4-fold higher in ES cells compared to 
unperturbed NIH-3t3 cells (lanes 1 and 7 and Figure S3A), indicating that high levels 
of Cdc25A persist even upon UV-induced DNA damage. Since cell cycle distribution 
of asynchronously growing ES and NIH-3t3 cells is different, we analysed Cdc25A 
abundance in synchronized cells (Figure 2B). We observed that in G1, ES cells 
contained about 7-fold more Cdc25A protein than NIH-3t3 cells (lanes 3 and 11 and 
Figure S3B). Proteolysis of Cdc25A mediated by the E3 ubiquitin ligase APCCdh1 
occurs at mitotic exit (Donzelli et al., 2002). Polyubiquitylated forms appear as a 
polypeptide ladder of higher molecular weight than the unmodified protein. In NIH-3t3 
cells synchronized in G1 and S phase, we could observe such ladders by western 
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blot using a specific Cdc25A antibody (Figure 2B, dark). Strikingly, in synchronized 
ES cells, these isoforms are much less abundant, whereas levels of unmodified 
Cdc25A are 7-fold higher than in NIH-3t3 cells (Figure S3B). Cdc25A 
immunoprecipitation from either ES or NIH-3t3 cells cotransfected with GFP-Cdc25A 
and HA-tagged ubiquitin, confirmed the presence of much more Cdc25A 
polyubiquitylated forms in NIH-3t3 than in ES cells (Figure 2C), corroborating recent 
data (Buckley et al., 2012). 
Next we tested whether incomplete Cdc25A degradation may be due to 
impaired function of the ATR-Chk1 pathway. To this end, we treated cells with a 
Chk1 inhibitor and analyzed Cdc25A protein levels upon UV irradiation. In contrast to 
a previous report in which degradation of Cdc25A was not affected by both Chk1 and 
Chk2 inhibitors (Koledova et al., 2010), we observed that Cdc25A degradation in ES 
cells is entirely dependent on Chk1 activity (Figure 2D). One explanation for this 
discrepancy may be that we analysed Cdc25A protein turnover in presence of 
cycloheximide to inhibit translation, since it is known that Cdc25A abundance is also 
regulated at this level (Gautier et al., 2012).  
Treatment of asynchronously growing ES cells with roscovitine (a selective 
CDKs inhibitor) induced dose-dependent increase of G1 cells and reduced the 
fraction of S phase cells (Figure S3C), demonstrating that, similar to somatic cells, in 
ES cells CDK activity is necessary for the G1/S transition. Inhibitory CDK2Y15 
phosphorylation is mediated by Wee1 kinase and relieved through dephosphorylation 
by Cdc25A (Busino et al., 2004; Malumbres and Barbacid, 2001). We therefore 
analysed changes in protein level of Wee1, Cdc25A, and CDK2Y15P during G1/S 
transition in ES cells, which, according to BrdU uptake experiments, occurs between 
2-3 hours after nocodazole release (Figure 1C). Mitotic exit was monitored by histone 
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H3 phosphorylation at serine 10 (H3S10P), and S phase entry by H3 and Cyclin A 
production. Interestingly, Wee1 levels did not show significant cell cycle-dependent 
variations, while Cdc25A levels decreased and inversely correlated with CDK2Y15P 
abundance (Figure S3D-E), suggesting that in ES cells, cell cycle-dependent 
fluctuation of Cdc25A levels may specifically regulate CDK2Y15P.  
To further pinpoint the specific role of Cdc25A in the G1/S checkpoint, we 
examined whether interfering with Cdc25A levels by RNAi affects S-phase entry 
upon DNA damage (Figure S3F-G). To avoid undesired differentiation of ES cells 
due to G1 phase extension upon Cdc25A downregulation that would interfere with 
the interpretation of this experiment (see below and Figure 6E-F), knockdown was 
performed over a short period (24 hours). Interestingly, Cdc25A knockdown (Figure 
2E) resulted in a significant, UV-dependent, increase of BrdU-negative cells with 2N 
DNA content (Figure 2F) mirrored by increased CDK2Y15P levels (Figure 2E, compare 
lane 3 with lane 6 and Figure S3H). Importantly, the slight increase of CDK2Y15P 
levels between 2 and 4 hours after release (Figure 2E, lane 3), also observed in 
synchronized undamaged cells entering S-phase (Figure S3D), did not result in an 
apparent difference in S phase entry in mock and UV-treated cells transfected with 
control RNAi (Figure 2F). Altogether, these data show that ES cells contain high 
levels of Cdc25A and that its knockdown leads to a UV-dependent G1 delay. 
 
 
ES cells express high Dub3 deubiquitylase  
Elevated Cdc25A protein levels can be explained by increased gene expression, 
increased translation or reduced protein degradation. We analysed protein turnover 
in the presence of cycloheximide to inhibit de novo protein synthesis (Figure S4A-B). 
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Using this approach, we found a 3-fold longer half-life of Cdc25A in ES cells  (t1/2= 24 
min) compared to NIH-3t3 cells (t1/2= 8 min). Of note, since unsynchronized cells 
were used, we cannot exclude that the observed difference is partly due to distinct 
cell cycle distribution of both cell types. However, this data strongly suggests 
alterations in protein stability that, according to data shown in Figure 2B-C, might 
reflect differences between polyubiquitylation and ubiquitin removal by hydrolysation 
(deubiquitylation). To address this point, we compared gene expression of Cdc25A, 
Cdh1, -TrCP and that of the recently described Dub3 deubiquitylase (Pereg et al., 
2010), between ES and NIH-3t3 cells. Whereas mRNA levels of Cdc25A, Cdh1 and 
TrCP in ES cells hardly differ from NIH-3t3 cells, Dub3 mRNA level was 4-fold 
higher in ES cells (Figure 3A). Moreover, RNAi-mediated knockdown of Dub3 in ES 
cells (Figure 3B) did not affect Cdc25A mRNA level (Figure 3C) but resulted in 3-fold 
reduction of Cdc25A protein abundance (Figure 3D). These data are consistent with 
previous work in human cells (Pereg et al., 2010) and indicate that Dub3 function in 
regulating Cdc25A protein stability is analogous in mouse ES cells. In addition, we 
also observed a role of Dub3 in Cdc25A stability in unperturbed and damaged NIH-
3t3 cells (Figure S4C-D). Of note, GFP-tagged Dub3 shows an exclusive nuclear 
localization (Figure 3E) as previously observed for Cdc25A in ES cells (Koledova et 
al., 2010). Finally, to address the role of Cdh1 and -TrCP in regulating Cdc25A 
levels in ES cells, we performed RNAi-mediated knockdown experiments. In contrast 
to Dub3 knockdown neither Cdh1, nor -TrCP downregulation affected Cdc25A 
mRNA expression nor did significantly alter Cdc25A stability (Figure S4E-F). These 
observations are consistent with a previous study showing that APC/Cdh1 activity is 
attenuated in ES cells by high levels of the Emi1 inhibitor (Ballabeni et al., 2011). 
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Orphan receptor Esrrb regulates Dub3 gene expression  
Based on previously described consensus sequence for binding motifs of key 
transcription factors involved in reprogramming (Chen et al., 2008; Thomson et al., 
2011), we analyzed the proximal promoter (6 kb) of the Dub3 gene. Strikingly, while 
no Oct4, Nanog, Klf4, Smad1, Stat3, c-Myc nor n-Myc consensus sites could be 
detected, we originally (NCBI37/mm9) found up to seven estrogen-related-receptor-b 
(Esrrb) putative binding motifs (consensus: 5’-TNAAGGTCA-3’)(Deblois et al., 2009) 
and two Sox2 putative response elements (consensus: 5’-CATTGTT-3’). However 
the latest update of this genomic sequence (GRCm38/mm10) displays only three 
Esrrb sites (Figure 4A, Esrrb-RE). Esrrb is a nuclear receptor belonging to the 
superfamily of nuclear hormone receptors. Together with Sox2, it is part of the core 
self-renewal machinery (Festuccia et al., 2012; Ivanova et al., 2006; Martello et al., 
2012). Esrrb knockdown using a previously validated RNAi sequence (Feng et al., 
2009) resulted in significant decrease of endogenous Dub3 transcript level (Figure 
4B), to a similar extent than the previously described Esrrb target gene Nanog (van 
den Berg et al., 2008). Inversely, ectopic expression of Esrrb in ES cells, and not of 
its C-terminal truncated form (∆-Cter) lacking the activation function 2 (AF2) domain, 
led to significant increase in endogenous Dub3 mRNA level (Figure 4C). Moreover, 
treatment of ES cells with increasing dose of DY131, a previously described selective 
Esrrb and Esrrg agonist (Yu and Forman, 2005), boosted Dub3 gene expression and 
increased Cdc25A protein abundance without affecting Cdc25A transcript level 
(Figure S5A-B). Inversely, Esrrb knockdown resulted in a 40% decrease of DY131-
mediated Dub3 transcription (Figure S5C), while Sox2 knockdown using a previously 
published RNAi sequence (Walker et al., 2007) did not strongly affected Dub3 
expression, though slightly increased it (our unpublished observations).  
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Next we performed chromatin immunoprecipitation (ChIP) experiments to map 
Esrrb and Sox2 binding to Dub3 promoter in ES cells. To this end, we designed five 
primer pairs (Figure 4A, pp) separated by approximately 1kb to scan promoter 
occupancy by Esrrb and Sox2 within the 6kb upstream of the start codon (ATG+1). 
Sonication of chromatin resulted in fragments under 500 bp, limiting signal overlap 
between primers (Figure S5D). ChIP analysis with an anti-Esrrb antibody (Figure 
S5E) shows that Esrrb binds to the proximal Dub3 promoter in regions containing the 
three Esrrb consensus binding motifs (Figure 4D, pp 3-5), while no Esrrb binding was 
observed in an upstream region that does not contain Esrrb binding sites (pp 1-2). 
On the contrary, ChIP analysis with an anti-Sox2 antibody showed high enrichment 
only at one of the two consensus sites in the Dub3 promoter (Sox2-RE2), around 
primer pair 3, while in the region containing the second site (Sox2-RE1, pp4-5) Sox2 
was bound to much lower levels.  
To corroborate abovementioned ChIP data, we cloned the Dub3 proximal 
promoter (3,2 kb) and analyzed its transcriptional activity in a reporter assay using 
luciferase activity as readout. For this purpose we used cells that have very low 
expression of endogenous steroid receptors (CV1 cells). As anticipated, we observed 
strong induction of luciferase activity upon Esrrb expression in cells cotransfected 
with the 3.2 kb Dub3 promoter that contains all three Esrrb binding sites (Figure 4E, 
Esrrb, white bars) while only background activity was observed on a region of the 
Dub3 promoter (5’ far) devoid of Esrrb consensus binding sites (Esrrb, black bars). 
Similarly, expression of Esrrb ∆-Cter, resulted in basal promoter activity, comparable 
to that observed by expression of empty vector (EV, Figure 4E and S5F). 
Interestingly, we did not observe stimulation of luciferase activity upon expression of 
Sox2, but a small and significant repression of basal promoter activity (Figure 4E). 
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Importantly, mutation of the unique Esrrb binding site in a 1kb Dub3 genomic 
fragment decreased transcriptional activity (Figure 4F). Altogether these observations 
suggest that Dub3 is a direct Esrrb target gene, having a positive role in regulating 
transcription of the Dub3 gene, while Sox2 on its own is not sufficient to stimulate 
Dub3 transcription.  
 
Developmental regulation of Dub3 expression and Cdc25A stability 
Esrrb is a pluripotency factor highly expressed in ES cells that, unlike Sox2, is 
strongly downregulated upon ES differentiation (Percharde et al., 2012). Since Dub3 
is an Esrrb target, we analyzed expression of Dub3 during neural conversion of ES 
cells in vitro. Plating of ES cells in N2B27 culture medium triggers conversion into 
neuroepithelial precursors (Ying et al., 2003) microscopically visible as rosette 
conformations (Figure 5A, day 7). Loss of pluripotency was monitored by expression 
analysis of specific markers such as Oct4, Nanog, Klf4, and acquisition of neural 
identity was monitored by Nestin and Sox1 expression. Specificity was controlled by 
analysis of Sox7 expression, a well-established endoderm marker (Figure S6A-B). 
Importantly, Nestin was detectable in just about each individual cell of the 
differentiating population at day 6, indicating homogenous neural conversion. Acute 
(within 24 hours) decrease of Esrrb mRNA expression preceded in time a marked 
and dramatic decrease of Dub3 expression (Figure 5B). Expression of Sox2 also 
decreased after 24 hours, however of only 50% and increased afterwards. In 
contrast, neither Cdc25A nor Cdh1 or -TrCP transcript levels significantly changed 
during differentiation (Figure 5B, middle panel). Expression analysis of three other 
deubiquitylases implicated in Cdc25A stability, USP13, 29 and 48 (Pereg et al., 2010) 
revealed a decrease of only USP48 within 24 hours after differentiation (Figure 5B, 
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lower panel) that mirrored Sox2 expression. Importantly, we could not find any 
consensus Esrrb binding sites within the USP48 proximal promoter. In contrast, 
USP13 gene expression did not significantly change during differentiation, while 
USP29 expression strongly increased during neural conversion. 
To analyze Dub3 protein levels we raised a specific antibody recognizing, as 
expected, a 60 kDa polypeptide in SDS-PAGE (Figure S6C-D). Dub3 protein levels 
dropped massively very early during differentiation, much earlier than Oct4, finely 
correlating with Dub3 mRNA levels (Figure 5C). Strikingly, lineage commitment 
between days 2-3, as monitored by Sox1 expression, led to a marked and continuous 
decrease of Cdc25A protein level, while the protein level of the two other Cdc25 
family members, Cdc25B and Cdc25C, remained constant during differentiation 
(Figure S6E). We further analyzed expression of two additional Dub3 substrates 
during differentiation, RhoA (de la Vega et al., 2011) and Suds3 (Ramakrishna et al., 
2011), and observed no significant variations in gene expression (Figure S6F), nor in 
protein stability (Figure 5C), although a small decrease in Suds3 level was seen at 
day 7 after differentiation. Finally, we found very low expression of Esrrg (another 
member of the subfamily) in ES cells that further increased during differentiation 
(Figure S6F), corroborating the specificity of Dub3 gene regulation by Esrrb. 
Altogether, these findings suggest that reduced Cdc25A protein abundance during 
neural differentiation is likely governed at the post-translational level.  
While retaining self-renewal properties, neural stem cells (NSC) are 
multipotent stem cells derived from ES cells, isolated and amplified at day 7 following 
differentiation. Quantification of Cdc25A abundance revealed 8-fold more Cdc25A in 
asynchronously growing ES cells compared to NSCs (Figure 5D). Similar to NIH-3t3 
cells, we detected very low Dub3 transcript levels in NSCs (Figure S6G). Finally, we 
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isolated and analyzed three different genomic fragments of the Dub3 promoter and 
compared basal transcriptional activity in NIH-3t3 versus ES cells. We observed 
strong transcriptional activity of all three promoter sequences in ES cells, about 10-
fold higher than in NIH-3t3 cells (Figure 5E), further corroborating mRNA expression 
during differentiation (Figure 5B).  
 
Dub3 expression is important for maintenance of pluripotency and cell cycle 
remodelling during differentiation 
Stable transfection of Esrrb in ES cells has been shown to be sufficient to sustain 
pluripotency in absence of LIF (Zhang et al., 2008). We therefore addressed whether 
forced Dub3 expression in ES cells could substitute Essrb function in maintaining 
pluripotency in absence of LIF. To this end, we generated a stable ES cell line, 
expanded from a single ES colony, expressing eGFP-Dub3 under control of a 
constitutive strong promoter (Figure 6A). Remarkably, while Pereg et al. (2012) 
reported that high Dub3 expression induces S-G2/M arrest in human somatic U2OS 
cells, ES cells overexpressing Dub3 could be propagated without significant 
differences in cell cycle distribution compared to a control cell line, indicating that in 
ES cells constitutive Dub3 expression is not toxic (Figure S7A-B). Removal of LIF led 
to an apparent highly similar morphological differentiation program in both cell-lines, 
but unexpectedly resulted in massive death of eGFP-Dub3-expressing ES cells two 
days after, microscopically visible as detached cells with retracted nuclei (Figure 6B, 
arrows). Of note, five days following LIF withdrawal, hardly any cell survived in the 
eGFP-Dub3 expressing cell-line. Caspase-3 activity, essential for proper 
differentiation (Fujita et al., 2008), was higher at days 3-4 in eGFP-Dub3 expressing 
cells compared to empty vector, strongly indicative of apoptosis (Figure 6C and 
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Figure S7C). Finally, whereas mRNA and protein levels of pluripotency and 
differentiation markers were highly comparable in both cell lines, we observed 
elevated expression of the apoptotic marker Noxa at day two and afterwards in 
eGFP-Dub3 expressing cells (Figure S7D).  
Remarkably, 2-3 days upon LIF removal, a strong reduction of eGFP-Dub3 
protein level was evident (Figure 6C), suggesting an additional control at post-
transcriptional level, very likely proteolysis, occurring during differentiation. A similar 
phenotype was observed upon N2B27-mediated neural conversion, and a similar 
result was also observed with a ES cell line expressing HA N-terminal-tagged Dub3 
(Figure S7E-F), ruling out a non-specific effect of the GFP tag or of the differentiation 
protocol used. Onset of apoptosis, was equally observed by FACS analysis (Figure 
6D), that showed the presence of subdiploid (less than 2N) cell debris starting from 
day three during differentiation and being predominant at day four. Interestingly, 
appearance of the sub-G1 cell population in ES cells expressing eGFP-Dub3 was 
concomitant to cell lineage commitment, as monitored by Sox1 and Nestin 
expression (Figure S6A) and cell cycle remodelling which started at day three in the 
control cell line (empty vector), resulting in lengthening of the G1 phase (Figure 6D). 
Altogether these results strongly suggest that high Dub3 expression is lethal during 
differentiation at the time when cell cycle remodelling occurs.  
Finally we analyzed the effect of Dub3 or Cdc25A knockdown in ES cells. 
Interestingly, prolonged (7 days) RNAi mediated Dub3 knockdown, resulted in an 
increase of alkaline phosphatase (AP)-negative colonies, as well as heterogeneous 
morphological differentiation of ES cells even in the presence of LIF, suggesting that 
Dub3 expression is important for maintenance of pluripotency (Fig 6E-F). A very 
similar result was also observed upon prolonged Cdc25A knockdown. In sum, these 
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data couple the self-renewal machinery of ES cells through Essrb to the master cell 
cycle regulator Cdc25A and remodelling of the cell cycle during differentiation 
through modulation of Dub3 expression. 
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Discussion 
In this study we dissected the G1/S checkpoint signalling pathway in ES cells. We 
found that ES cells maintain high levels of the Cdc25A phosphatase in G1 that 
persists even after DNA damage. Knockdown of Cdc25A expression resulted in a G1 
delay and increased CDK2Y15P after UV damage within 24 hours post RNAi treatment 
(a condition required to avoid natural G1 phase expansion due to differentiation of ES 
cells). Indeed, prolonged Cdc25A downregulation (or Dub3), resulted in cell 
differentiation in the presence of LIF, in line with the notion that lengthening of the G1 
phase and deregulation of CDK2 activity is linked to differentiation (White et al., 
2005). These findings provide an explanation for absent regulation of CDK2 activity 
upon DNA damage in ES cells (Koledova et al., 2010). This model is also in line with 
existing evidence linking elevated Cdc25A expression with impaired G1/S arrest 
followed by radioresistant DNA synthesis in cancer cells (Falck et al., 2001). 
Interestingly, in addition to Cdc25A, we have also observed down-regulation of 
Cyclin E (Figure S6H), another CDK2 regulator that is rate limiting during the G1/S 
transition and opposes spontaneous differentiation of naïve ES cells (Coronado et 
al., 2012). Moreover, ablation of the SCFFbw7-mediated degradation pathway 
controlling Cyclin E abundance in vivo results in impaired differentiation, genomic 
instability and hyperproliferation (Minella et al., 2008), illustrating the importance of 
Cyclin E regulation in mouse development. Taken together, both reduced abundance 
of Cdc25A and Cyclin E during differentiation of ES cells, likely embody key 
molecular adaptations that control CDK activity and consequent G1 lengthening. 
Importantly, as a result of expanded G1, the p53-dependent response may now 
become more effective in CDK2 inhibition since this requires a slow transcriptional-
dependent induction of the CDK inhibitor p21 protein level. It is anticipated that p21 
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may have virtually no role in CDK2 regulation in ES cells since these cells spend 
most of their time in S phase and p21 is efficiently degraded by the PCNA-dependent 
CRL4Cdt2 ubiquitin ligase throughout S phase, as well as after DNA damage (Abbas 
et al., 2008).  
 We have provided evidence that post-transcriptional regulation of Cdc25A 
abundance in ES cells depends upon the Dub3 deubiquitylase. Expression of Dub3, 
and not Cdh1 or -TrCP, is higher in ES cells compared to differentiated cells, and 
knockdown of Cdh1 or -TrCP did not significantly change the stability of Cdc25A 
since it is already highly stabilized in ES cells. These observations are consistent 
with the finding that ES cells have attenuated APC activity that increases during 
differentiation (Ballabeni et al., 2011). Of the four additional deubiquitylases 
implicated in Cdc25A stability in human cells (USP13, 29, 48 and Dub2A), we found 
that only USP48 mRNA levels significantly decreased during differentiation although 
its expression remained high and increased towards the end of differentiation, 
mirroring Sox2 expression. Hence, although we cannot exclude a redundant role for 
Dub2A and USP48 in Cdc25A stability during differentiation, our data support a key 
role for Dub3 in this process, as previously shown in somatic cells (Pereg et al., 
2010), and suggest that in ES cells the balance of ubiquitylation and deubiquitylation 
activities, which fine-tunes the steady-state level of Cdc25A, is shifted towards 
deubiquitylation due to high Dub3 expression. 
We showed that downregulation of Esrrb negatively affected the endogenous 
expression of the Dub3 gene, to a similar extent than a previously characterized 
Esrrb target gene, Nanog (van den Berg et al., 2008). However, expression of Oct4, 
another Esrrb target (Zhang et al., 2008) was not found to be much affected by Esrrb 
knockdown (van den Berg et al., 2008). These differences likely exist because in ES 
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cells, expression of pluripotency genes is under the combinatorial control of 
transcription factors of the pluripotency gene regulatory network (van den Berg et al., 
2008). This transcriptional control appears to be very complex, gene-specific and 
remains to be further clarified. 
We observed that while forced Dub3 expression could not inhibit differentiation 
upon LIF withdrawal, unexpectedly it induced massive apoptosis during 
differentiation concomitant to lineage commitment and cell cycle remodelling, such as 
lengthening of the G1 phase. These observations are in line with the recent finding 
that expression of non-degradable Cdc25A mutants leads to early embryonic lethality 
in mice (E3.5) showing the importance of fine-tuning the expression level of Cdc25A 
already at the oocyte and morula stages (Bahassi el et al., 2011). Although we have 
shown that Cdc25A is a critical Dub3 substrate in ES cells, we cannot exclude the 
implication of other Dub3 substrates (de la Vega et al., 2011; Ramakrishna et al., 
2011) in the toxicity observed by forced Dub3 expression during differentiation. The 
importance of tight Cdc25A regulation during embryogenesis is also underscored by 
its function in regulation of pluripotency versus differentiation of ES cells since 
Cdc25A is expressed in progenitor cells undergoing proliferative self-renewing 
divisions (Peco et al., 2012). We speculate that this developmental regulation might 
be governed by Dub3 to modify cell cycle dynamics under control of Esrrb.  
In conclusion our results couple the Cdc25A-CDK2 cell cycle signalling 
pathway to the self-renewal machinery through Esrrb-dependent regulation of Dub3 
in ES cells, and highlight the importance of deubiquitylases in stem cell and 
developmental biology. Since cell cycle regulation is a rate-limiting step in 
reprogramming processes, these findings put Dub3 and Cdc25A as interesting 
candidate genes in cell reprogramming. 
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Experimental Procedures 
Cell extracts, western blotting and antibodies 
Cells were rinsed once in PBS and incubated in lysis buffer. Whole cell extracts were 
clarified by centrifugation at 12000 g for 10 min at 4°C. Protein concentration of was 
estimated by BCA (Pierce; see Supplemental information).  
 
Cell culture and transfection 
ES cells (CGR8) were cultured on gelatin-coated dishes in the absence of feeder 
cells with 1,000 U LIF per ml (Millipore). Cells were grown in a humidified 
atmosphere of 5% CO2 at 37°C. For transient expression both NIH-3t3 and ES cells 
were transfected using X-tremeGENE 9 DNA (Roche), and CV1 with JetPEI 
(Polyplus), according to manufacturer's directions. For infection, retroviral particles 
were generated by transfecting Platinum-E ecotropic packaging cell line with 
retroviral expression vector (pLPC) encoding Myc6-Dub3 variants using home-made 
PEI reagent.  
 
Cell synchronization 
ES cells were arrested in prometaphase by nocodazole (Sigma) for 4-8 hours. After 
mitotic-shake off cells were washed 3 times in ice-cold PBS and dissolved in full ES 
growth medium. Cells were incubated in a humidified atmosphere of 5% CO2 at 37°C 
for 45 minutes and placed at 30°C for 1 hour to reduce S phase entry. Cells were 
mock- or UV-irradiated (6 J/m2) and incubated at 37°C prior collection. To 
synchronise NIH-3t3 cells in G0 cells were grown to confluence and incubated for 2-3 
days. Next, cells were washed, resuspended and split at 30% confluency. Six hours 
after release, cells were UV-irradiated.  
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UV-induced DNA Damage and Drugs 
UV-C irradiation at 254nm was performed with microprocessor-controlled crosslinker 
(BIO-LINK ®) or with a UV-lamp (Hanovia). Cycloheximide and DY131 (GW4716) 
were from Sigma and Chk1 inhibitor SB218078 from Calbochiem. 
 
Flow cytometry 
Single-cell suspensions were prepared by trypsinisation and washed once in PBS. 
Cells were fixed in ice-cold 70% ethanol (-20°C) and stored at -20 °C overnight. 
Following RNAse A treatment, total DNA was stained with propidium iodide (25 
µg/ml). For BrdU uptake analysis, ES cells and NIH-3t3 cells were grown in the 
presence of 10 µM BrdU for respectively 10 and 30 minutes. The BrdU content was 
determined by reaction with a fluorescein isothiocyanate (FITC)-conjugated anti-BrdU 
antibody (BD Biosciences). Cells were analyzed with a FACScalibur flow cytometer 
using CellQuestPro software. 
 
RNA extraction, reverse transcription and quantitative real-time PCR 
Total RNA was isolated with TRIzol reagent (Invitrogen). Reverse transcription was 
carried out with random hexanucleotides (Sigma) and Superscript II First-Strand 
cDNA synthesis kit (Invitrogen). Quantitative PCRs were performed using Lightcycler 
SYBR Green I Master mix (Roche) on Lightcycler apparatus (Roche). All primers 
used were intronspanning (primer sequences available upon request). The relative 
amount of target cDNA was obtained by normalisation using geometric averaging of 
multiple internal control genes (ACTB, HPRT, HMBS, GAPDH, SDHA). 
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Chromatin Immunoprecipitation 
ES cells were formaldehyde cross-linked and sonicated using a Misonix sonicator S-
4000. Cells were lysed in ice-cold lysis buffer (Supplemental Information). Primer 
pairs for promoter scanning (6 kb upstream of transcription start site, TSS) of the 
Dub3 murine promoter were designed approximately every 1 kb. 
 
Monolayer differentiation of ES cells into neurectodermal precursors 
This protocol was as previously described (Ying et al., 2003). (see also Supplemental 
information).  
 
Isolation and amplification of NSC cells from CGR8 ES cells 
ES cells were induced to differentiate into NSC following the protocol described 
above. At day 6, cells were dissociated in 0.01% Trypsine-EDTA and plated onto 
Poly-L-Ornithine/Laminin coated dishes in DMEM/N2 medium with 10 ng/ml of both 
EGF and bFGF (Biosource). For the preparation of Poly-L-Ornithine/Laminin plates, a 
0.01% solution of poly-L-ornithine (Sigma) was added to plates for at least 20 min. 
The solution was removed and plates were washed 3 times with PBS. A 1 µg/ml 
solution of laminin in PBS (Sigma) was then applied and incubated at 37°C for at 
least 3 hrs. Cells can then be cultivated and amplified under these conditions for 
several subpassages without loosing neural stem cells properties. 
 
Establishment of a monoclonal eGFP-Dub3 expressing ES cells 
Wild-type ES cells were transfected with pcDNA3-eGFPDub3, plated at clonal 
density and selected with G418 (Sigma). eGFP-Dub3 positive clones were expanded 
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in continuous presence of G418 and validated by immunofluorescence and western 
blotting. 
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Figure Legends 
Figure 1: DNA damage in G1 induces transient ES cell cycle arrest in early S-phase 
and not at the G1/S transition.  
(A) Schematic overview of the experimental design. Arrows indicate time points at 
which cells were collected.  
(B) FACS analysis of ES cells released from nocodazole arrest, mock (left panel) or 
exposed to 6 J/m2 UV light (right panel) in G1. Analysis of total DNA content stained 
by propidium iodide at indicated time points.  
(C-D) Kinetics of S phase entry of synchronised ES cells, mock and UV-irradiated (6 
J/m2) in G1. Cell cycle distribution was measured by BrdU incorporation followed by 
FACS analysis.  
(E) Representative FACS analysis of S-phase entry by analysis of BrdU 
immunoreactivity of ES and NIH-3t3 cells exposed respectively to 6 and 10 J/m2 UV 
light in G1. Box indicates region were differences in total events was observed. Mean 
fluorescence intensity of BrdU-positive cells is shown. (see also Figure S1). 
 
Figure 2: Persistence of Cdc25A upon DNA damage in G1 sustains G1/S checkpoint 
bypass in ES cells. 
(A) Asynchronously growing ES and NIH-3t3 cells were exposed to 10 J/m2 of UV-
light, collected and analyzed by western blotting at the indicated times. For Cdc25A, 
a dark and light exposure is shown. 
(B) Abundance of Cdc25A in ES and NIH-3t3 cells synchronized in G1 and passing 
through S phase. ES cells were synchronized by nocodazole and collected upon 
release at indicated time points. NIH-3t3 cells were synchronized by confluence, 
released and collected at 6 hours (G1) and 18 hours (S) after release. To observe 
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posttranslational modifications (PTM) of Cdc25A, dark and light western blot 
exposure is shown. 
(C) Western blot analysis of Flag-immunoprecipitated, ectopically expressed Flag-
Cdc25A cotransfected with HA-ubiquitin in ES (lane 1) and NIH-3t3 cells (lane 2) 
after MG132 treatment for 1 hour. IgGs indicates immunoglobulins. 
(D) Rapid Cdc25A destruction upon DNA damage is Chk1-dependent in ES cells. 
Cells were UV-irradiated and incubated with cycloheximide (Cx) in absence or 
presence of Chk1 inhibitor SB218078, collected at the indicated times (min) and 
analyzed by western blotting.  
(E) Downregulation of Cdc25A expression by RNAi results in increased inhibitory 
CDK2Tyr15 phosphorylation upon DNA damage in G1. RNAi-transfected cells were 
released from nocodazole and exposed to UV-light in G1. Samples were collected at 
the indicated times and analyzed by western blotting with the indicated antibodies. 
(F) Cdc25A downregulation results in G1 delay upon DNA damage. RNAi-transfected 
cells were released from nocodazole and exposed to UV light in G1 (t=2) and 
collected 2 hours (t=4) after UV- or mock-irradiation. Prior to collection cells were 
pulse-labelled with BrdU. Fraction (expressed as %) of diploid BrdU negative cells is 
plotted (data are represented as mean  SD). Statistical differences is indicated with 
a single asterisk (*) for P < 0.05. (see also Figure S3). 
 
Figure 3: Elevated deubiquitylase Dub3 in ES cells increases Cdc25A abundance. 
(A) qPCR quantification of Oct4, Cdc25A, Cdh1, -TrCP and Dub3 mRNA 
normalized to multiple reference genes in ES and NIH-3t3 cells. Data are expressed 
as mean  SD (error bars) of multiple observations. Statistical differences is indicated 
with an asterisk P < 0.05. 
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(B) qPCR quantification of Dub3 mRNA normalised to multiple reference genes. ES 
cells were transfected with control (Crtl), Dub3 or Cdc25A RNAi sequences. 
(C) qPCR quantification of Cdc25A mRNA normalised to multiple reference genes. 
ES cells were transfected with control (Crtl), Dub3 or Cdc25A RNAi sequences. 
(D) Western blot analysis of ES cells transfected with Dub3, Cdc25A or control (Crtl) 
RNAi sequences.  
(E) Cellular localisation of pcDNA3-eGFP-Dub3 in ES cells. Nuclei were 
counterstained using DAPI. Scale bar 10 µM. (See also Figure S4). 
 
Figure 4: Dub3 is a target gene of the orphan receptor Esrrb. 
(A) Schematic overview of the Dub3 proximal promoter in mouse (6kb). Esrrb 
(shaded boxes) and Sox2 (green boxes) consensus binding sites (RE) are indicated. 
(B) qPCR quantification of Esrrb, Dub3 and Nanog mRNA normalised to multiple 
reference genes expressed as % of control. ES cells were transfected with control 
(Crtl) RNAi (white bars) or Esrrb specific RNAi sequence (black bars). Data are 
expressed as mean  SD (error bars) of multiple observations. Statistical differences 
is indicated with a single asterisk (*) for P < 0.05, not significant is indicated as (ns). 
(C) qPCR quantification of endogenous Dub3 expression in ES cells transfected with 
empty vector (EV), Esrrb or Esrrb-Cter expressing plasmids. Data are expressed as 
mean  SD (error bars) of multiple observations. Statistical differences is indicated 
with a single asterisk (*) for P < 0.05. 
(D) ChIP of Esrrb and Sox2 on Dub3 promoter. Primer pair location along the 6 kb 
proximal promoter (Figure 4A) for scanning of Dub3 promoter for Esrrb and Sox2 
occupancy. Data are expressed as mean  SD (error bars) of multiple observations. 
 29 
Amylase serves here as a control. Statistical analysis using two-way ANOVA was 
performed. 
(E) Dub3 promoter activity using luciferase assay in CV1 cells. Cells were 
cotransfected with promoter construct and the indicated genes, and assessed for 
luciferase activity 48 hours post-transfection. Bars represent the fold induction  SD 
of multiple observations. Statistical differences is indicated with a single asterisk (*) 
for P < 0.05 and (**) for P < 0.001. 
(F) Basal transcriptional activity of a 1 kb proximal promoter and a mutated sequence 
in ES cells. Three mutations were introduced in the Esrrb consensus binding site. 
TCAAGGTCA was mutated to TCATTTTCA. Data are expressed as mean  SD 
(error bars) of multiple observations (see also Figure S5).  
 
Figure 5: Developmental regulation of Cdc25A protein abundance correlates with 
Dub3 expression. 
(A) N2B27-induced neural conversion of ES cells. Phase-contrast photos at indicated 
days of differentiation.  
(B) qPCR quantification of indicated mRNA normalised to multiple reference genes 
during N2B27-induced neural differentiation. Values represent mean  SD of multiple 
observations. 
 (C) Western blot analysis of cell extracts collected throughout differentiation of ES 
cells into neural stem cells (NSC) immunoblotted with the indicated antibodies. 
(D) Western blot analysis of asynchronously growing ES and NSC. Cells were 
exposed to 6 J/m2 UV-light and collected at indicated times. 
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(E) Basal transcriptional activity of three different promoter lengths of the Dub3 gene 
analysed in NIH-3t3 cells and ES cells. Data are expressed as mean  SD (error 
bars) of multiple observations (see also Figure S6). 
 
Figure 6: Constitutive Dub3 expression leads to massive apoptosis concomitant to 
differentiation-induced cell cycle remodeling. 
(A) Immunofluorescence detection of empty vector (EV) or eGFP-Dub3-expressing 
cells. All ES cells express eGFP-Dub3 at comparable levels. DNA was visualized by 
DAPI staining. 
(B) Phase-contrast photos of empty vector (EV) or eGFP-Dub3-expressing ES cells 
after LIF removal at the indicated days of differentiation. Arrows indicate detached 
cells with apoptotic morphology. 
(C) Western blot of cell extracts prepared every day after LIF withdrawal from empty 
vector or eGFP-Dub3-expressing ES cells. (*) indicates a non-specific band. High 
caspase 3 activities in eGFP-Dub3 expressing cells indicate apoptosis.  
(D) Differentiation-induced cell cycle remodelling. Cells were collected at the 
indicated days and analyzed by FACS following propidium iodide staining. Cell death 
is illustrated by cells with subdiploid DNA content (Sub-G1). 
(E) Clonogenic assay of ES cells upon prolonged control or Dub3 targeting RNAi 
sequence. Cells were plated at clonal density in LIF-containing serum and stained for 
AP after 7 days. Columns show the percentage of AP positive (Pos.) or negative 
(Neg.) colonies. At least 150 colonies were scored.   
(F) Representative pictures of cells transfected with control or Dub3 targeting RNAi 
sequence and assayed for AP activity (see also Figure S7). 
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Supplemental information: 
 
Seven Supplemental Figures, Figures legends and Supplemental experimental 
procedures. 
 
Figure S1 (related to Figure 1). Shows additional information providing evidence for an 
arrest of mouse embryonic stem cells in early S phase and not in G1 upon UV damage. 
 
Figure S2 (related to Figure 1). Shows that the p53 transcriptional response is functional 
in mouse embryonic stem cells upon UV damage. 
 
Figure S3 (related to Figure 2). Provides additional information showing that Cdcd25A is 
more abundant in mouse embryonic stem cells than in differentiated NIH-3T3 cells and 
that the G1/S transition in mouse embryonic stem cells requires CDK2 activity. It also 
shows that fluctuation of Cdc25A levels correlate with changes in CDK2 tyrosine 15 
phosphorylation which is increased following Cdc25A downregulation upon UV damage. 
Inventory of Supplemental Information
 Figure S4 (related to Figure 3). Provides evidence that Cdc25A half-life is higher in 
mouse embryonic stem cells than in differentiated NIH-3T3 cells. Moreover it provides 
supplementary evidence that Dub3 and not Cdh1 nor b-TRCP regulates Cdc25A stability 
in mouse embryonic stem cells. 
 
Figure S5 (related to Figure 4). Shows that the Esrrb and Esrrg agonist DY131 boosts 
Dub3 expression in mouse embryonic stem cells. It also provides important controls for 
the Chip experiments. 
 
Figure S6 (related to Figure 5). Provides additional data essential to control the 
differentiation of mouse embryonic stem cells into neural stem cells (NSCs), essential to 
interpret the results shown in Figure 5. It also shows the specificity of the mouse Dub3 
antibody. 
 
Figure S7 (related to Figure 6). Provides additional information for the cell death 
observed in mouse embryonic stem cells expressing eGFP-Dub3 and undergoing 
differentiation. It also shows that a similar phenotype is observed in cells expressing HA-
Dub3. 
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Supplemental Figure legends 
Figure S1 (related to Figure 1): DNA damage in G1 induces transient cell cycle 
arrest in early S-phase and not at the G1/S transition.  
(A) UV-dependent cell cycle changes of ES Cells. Cell cycle profile of 
asynchronously growing ES cells exposed to increasing dose of UV-light (2-10 J/m2). 
Cells were collected 6 hours after UV-irradiation for FACS analysis. 
(B) Cell cycle profile of UV-exposed ES cells in time. Asynchronously growing ES 
cells were exposed to 6 J/m2 UV-irradiation and collected for FACS analysis at 
indicated time points. 
(C) Immunofluorescence detection of Oct4 in ES and NIH-3t3 cells. Nuclei were 
counterstained using DAPI. Scale bar 10 µM. 
(D) Subcellular fractionation of ES cells released from nocodazole arrest, mock or 
UV-irradiated in G1 (2 hours after release) collected at indicated time points. Cells 
were lysed and fractionated into soluble and insoluble (chromatin-bound) fraction as 
described in Materials and methods. 
 (E) qPCR quantification of Cyclin E1 and Cyclin A2 mRNA normalised to multiple 
reference genes from ES cells released from nocodazole arrest mock or UV-
irradiated in G1 and collected at indicated time points. Dotted line represents levels in 
G1. Data are expressed as mean ± SD (error bars) of multiple observations.   
 
 
 
 
 
Figure S2 (related to Figure 1): p53 is transcriptionally active in ES cells upon DNA 
damage. 
(A) Subcellular fractionation of ES cells UV-irradiated and collected at indicated time 
points. Cells were lysed and fractionated into soluble and insoluble (chromatin-
bound) fraction as described in Materials and methods.  
(B) ES cells transfected with pG13-luc promoter (containing p53 response elements) 
were mock or UV-irradiated and processed for luciferase activity. Bars represent the 
mean ± SD of triplicate observations. 
(C) ES cells transfected with p21-luc and p21-ΔREp53-luc (lacking p53 response 
element) were mock or UV-irradiated and processed for luciferase activity. Bars 
represent the mean ± SD of triplicate observations. 
(D) qPCR quantification of p53, p21 and Mdm2 mRNA normalised to multiple 
reference genes. Wild-type (wt) and p53 knockout (p53-/-) ES cells were UV-irradiated 
and collected at indicated time points for analysis of mRNA expression of main p53 
target genes. Bars represent the mean ± SD of triplicate observations. 
 
Figure S3 (related to Figure 2): Persistent Cdc25A phosphatase upon DNA 
damage in G1 inhibits G1/S checkpoint in ES cells. 
(A) Quantification of western blotting signals shown in Fig. 2A Western blot signals 
(lane 1 and lane 7) of Cdc25A (dark exposure) were quantified by densitometry 
scanning and expressed as relative optical density (ROD) compared to β-actin signal 
as loading control. 
(B) Quantification of western blotting signals shown in Figure 2B. Western blot 
signals of Cdc25A were quantified by densitometry scanning and expressed as 
relative optical density (ROD) compared to β-actin signal as loading control.  
(C) Roscovitine, a potent and selective inhibitor of cyclin-dependent kinases, 
dependent lengthening of the G1 phase of ES cells. FACS analysis of 
asynchronously growing ES cells treated with increasing concentration of 
Roscovitine. 
(D) Cdk2 phosphorylation status (Y15P) during an unperturbed cell cycle. ES cells 
were released from nocodazole arrest and collected in G1 and S-phase at indicated 
time points. Proteins were detected with the indicated specific antibodies by western 
blotting. 
(E) Schematic representation of the regulation of phosphorylation on Cdk2 by Wee1 
and Cdc25A. Western blot signals of panel (C) were quantified by densitometry 
scanning and expressed as relative optical density (ROD) compared to β-actin signal 
as loading control. 
(F) qPCR quantification of Cdc25A mRNA normalized to multiple reference genes 
expressed as percentage of control. ES cells were transfected with control (Crtl) 
RNAi or Cdc25A RNAi sequences. Bars represent the mean ± SD of multiple 
observations. 
(G) Western blot analysis of ES cells transfected with control (Crtl) or Cdc25A RNAi 
sequences. 
(H) Quantification of western blotting signals shown in Figure 2E. Western blot 
signals of Fig. 2E were quantified by densitometry scanning and expressed as 
relative optical density (ROD) compared to Chk1 signal as loading control.  
Figure S4 (related to Figure 3): Elevated deubiquitylating enzyme Dub3 in ES cells 
results in Cdc25A abundance. 
(A) Representative western blot signal used for determination of Cdc25A turnover 
rate in the presence of cycloheximide (Cx) in ES and NIH-3t3 cells. Cells were 
collected at indicated time points.  
(B) Cdc25A turnover rate in the presence of cycloheximide (Cx) in ES and NIH-3t3  
cells. Western blot signals of Cdc25A were quantified by densitometry scanning and 
expressed as relative optical density (ROD) compared to β-actin signal as loading 
control. Signal in untreated cells were set at 100% and half-life (t1/2) of Cdc25A was 
determined (data are represented as mean ± SD). 
(C) Overexpression of Dub3 increases Cdc25A abundance. NIH-3t3 cells were 
transduced with empty vector (E.v.) or pLPC encoding Myc6-Dub3. After puromycin 
selection cells were collected and processed for western blot analysis. 
(D) Cdc25A degradation upon DNA damage in NIH-3t3 cells expressing empty vector 
(E.v.) or pLPC encoding Myc6-Dub3. Cells were collected at indicated time points and 
analyzed by western blotting. 
(E) qPCR quantification of indicated mRNA normalised to multiple reference genes 
expressed as percentage of control. ES cells were transfected with control (Luc), β-
TrCP, Cdh1 or Dub3 RNAi sequences and collected 48 hours after transfection. Bars 
represent the mean ± SD of triplicate observations. 
(F) Western blot analysis of Cdc25A protein in RNAi-transfected cells.  
 
 
 
Figure S5 (related to Figure 4): Dub3 is a target gene of the orphan receptor Esrrb 
(A) qPCR quantification of Cdc25A and Dub3 mRNA in ES cells treated with 
increasing concentration of the selective Esrrb and Esrrg agonist DY131 for 16 hours. 
Bars represent the fold induction ± SD of triplicate observations. 
(B) Western blot analysis of Cdc25A protein levels in ES cells treated with increasing 
concentration of the DY131agonist for 16 hours. 
(C) qPCR quantification of Esrrb and Dub3 mRNA normalised to multiple reference 
genes expressed as percentage of control in presence of DY131. ES cells were 
transfected with control (Crtl) RNAi (white bars) or Esrrb specific RNAi sequence 
(black bars). Data are expressed as mean ± SD (error bars) of multiple observations. 
(D) DNA fragments size prior to ChIP analysis. Sonication resulted to DNA fragments 
smaller than 500bp. 
(E) Specificity of the Esrrb antibody. Immunoprecipitation of 293T-HEK cells 
transfected with either empty vector (Ev) or Flag-Esrrb expression plasmids. 
Immunoprecipitation was performed in parallel using either Flag or Esrrb antibody.  
Both antibodies specifically immunopreciptated Flag-Esrrb protein.  
(F) Western blot analysis of expression levels of CV1 cells transfected with either 
empty vector (lane 1), Flag-Esrrb (lane 2), Flag-Esrrb Δ-Cter (lane 3) or Sox2 (lane 
4), 48 hours post-transfection.  
Figure S6 (related to Figure 5): Developmental regulation of Cdc25A protein 
abundance correlates with Dub3 expression levels. 
(A) qPCR quantification of pluripotency and cell fate specification markers during 
neural conversion of ES cells. Data were normalized to multiple reference genes. 
Data are expressed as mean ± SD (error bars) of multiple observations. 
(B) Immunofluorescence detection of Nestin at day 1 and day 6 of N2B27-induced 
differentiation. Nuclei were counterstained using DAPI. Scale bar 50 µM. 
(C) Specificity of the antibody raised against mouse Dub3. Human 293T cells were 
transfected with empty vector (EV) or HA-Dub3 expressing vectors. Cells were 
collected 24 hours post transfection and extracts were immunoblotted (IB) using pre-
immune (PI), Dub3 or HA antibodies. The Dub3 antibody recognizes a specific 
polypeptide of 60 kDa in SDS-PAGE (arrow) which is not recognized by the pre-
immune serum. 
(D) Validation of the antibody raised against mouse Dub3. Western blot analysis of 
ES cells transfected with control (lane 1) or Dub3 (lane 2) RNAi sequences. Cells 
were collected 48 hours post transfection and extracts were immunoblotted using 
Dub3 purified antibody and β-actin. 
(E) Western blot analysis of Dub3 substrates and indicated proteins during neural 
conversion. 
(F) qPCR quantification of Suds3, RhoA and Esrr g during neural conversion of ES 
cells. Data were normalized to multiple reference genes. Data are expressed as 
mean ± SD (error bars) of multiple observations. 
(G) qPCR quantification of Nestin, Nanog, Cdc25A and Dub3 mRNA normalized to 
multiple reference genes in ES and Neural Stem Cells (NSC). Bars represent the 
mean ± SD of multiple observations. 
(H) qPCR quantification of G1 cyclin stoechiometry during neural conversion of ES 
cells. Data were normalised to multiple reference genes. Data are expressed as 
mean ± SD (error bars) of multiple observations. 
 
Figure S7 (related to Figure 6): Constitutive Dub3 expression leads to massive 
apoptosis concomitant to differentiation-induced cell cycle remodeling. 
(A) Cell cycle distribution and BrdU incorporation of empty vector (EV) and eGFP-
Dub3 expressing ES cells analysed by FACS. 
(B) Phase contrast photos of eGFP-Dub3 and EV expressing cell-lines. 
(C) Immunoflorescnece detection of active capsase 3 during LIF withdrawal in empty 
vector and eGFP-Dub3 expressing ES cells.  
(D) qPCR quantification of pluripotency markers (Nanog, Klf4, Oct4, Rex1), of Sox7 
and of Noxa normalised to multiple reference genes during LIF withdrawal. 
(E) Western blot analysis of cell extracts collected every day throughout the N2B27-
induced differentiation process of empty vector or eGFP-Dub3 expressing ES cells 
into NSCs. Of note, four days after N2B27-mediated differentiation all eGFP-Dub3 
expressing cells were all dead by apoptosis as indicated by high caspase 3 activities. 
(F) Western blot analysis of cell extracts collected every day throughout the 
differentiation process of empty vector or HA-Dub3 expressing ES cells into NSCs. 
The molecular and cellular phenotype of HA-Dub3 expressing cells was highly 
comparable to the eGFP-Dub3 expressing cells indicating that the phenotype is 
independent of the N-terminal tag. 
 
Supplemental Experimental Procedures 
 
Cell culture and transfection 
Briefly, ES cells were maintained in Glasgow MEM BHK-21 (GMEM) supplemented 
with 10% fetal bovine serum, non-essential amino acids, L-glutamine, sodium 
pyruvate, β-mercapthethanol. NIH-3t3 cells were maintained in Dulbeccoʼs modified 
eagleʼs medium (DMEM) supplemented with 10% fetal bovine serum, 2 mM 
glutamine and antibiotics. The viruses-containing conditioned medium was incubated 
on exponentially growing NIH-3t3 cells for 24 hours in the presence of polybrene (10 
mg/mL). 48 hours post-infection, cells were selected in puromycin (2.5 µg/mL)-
containing medium for 8-10 days before use. Reverse transfection of ES cells was 
performed using INTERFERin (Polyplus) according to manufacturerʼs directions. 
Cells were collected 24, 36 or 48 hours after transfection for analysis. The Cdc25A 
RNAi sequence was 5ʼ-GAAAUUUCCCUGACGAGAA-3ʼ, Dub3 5ʼ-
GGCUGUAAGAUGUGUGCUA-3ʼ and a Esrrb previously described (Feng et al., 
2009). RNAi for Cdh1 and β-TrCP knockdown were purchased from Darmacon 
(SMARTpool) 57371 (Cdh1) and 12234 (β-TrCP). 
 
Monolayer differentiation of ES cells into neurectodermal precursors. 
ES cells were dissociated and plated in N2B27 medium onto 0.1% gelatine-coated 
dishes at a density of 1.104 cells/cm². N2B27 medium is a 1:1 mixture of DMEM/F12 
(Gibco) supplemented with modified N2 (25 µg/ml insulin, 100 µg/ml apo-transferrin, 
6 ng/ml progesterone (Sigma), 16 µg/ml putrescine (Sigma), 30 nM sodium selenite 
(Sigma), 50 µg/ml bovine serum albumine (Gibco), Neurobasal medium supplemeted 
with B27 (Gibco), β-mercaptoethanol (0.1 mM) and glutamate (0.2 mM) was also 
added. The medium was replaced every two days until day 7. 
 
Plasmids 
The murine Dub3 gene (Gene ID: 625530) was amplified by PCR and cloned into 
pLPC-Myc6, pcDNA3-GFP and pcDNA3-HA. All constructs were verified by DNA 
sequencing. Mouse Esrrb (pSG5FI-mEsrrb) and the C-terminal truncated pSG5FI-
mEsrrb-ΔCter were previously described (Vanacker et al., 1999). Genomic 
sequences of the Dub3 promoter were amplified by PCR and inserted into pGL4.10 
vector (Promega) for luciferase activity. pCEP4-Sox2 was a kind gift of F. Poulat 
(IGH-CNRS). 
 
 
Cell extracts, western blotting and antibodies 
Cells were rinsed once in PBS and then incubated with ice cold lysis buffer (50 mM 
Tris-HCl pH 7.4, 100 mM NaCl, 50 mM NaF, 5 mM EDTA, 40 mM β-glycero-
phosphate, 1% Triton X-100 and protease inhibitors) for 30 min on ice before 
scraping. Whole cell extracts were clarified by centrifugation at 12000 rcf for 10 min 
at 4°C. Protein concentration of the clarified lysates was estimated using BCA 
method (Pierce). Equal amount of protein was used for western blot analysis. All 
antibodies were incubated overnight at 4 °C in phosphate-buffered saline (PBS) 
containing 1% BSA and 0,1% Tween (Sigma). Antibodies used from Cell Signaling: 
Chk1S345P (2341), p53S15P (9284), γH2AX (2577), CDK2Y15P (9111), Myc-Tag (2276); 
active caspase 3 (9961); p53S15P (9284), γH2AX (2577); Active caspase 3 (9961); 
Abcam: DNA polα  (ab31777), H3 (ab1791), CDK2 (ab6538), PSTAIR (ab10345), 
GFP (ab290), DNA polα (ab31777), H3 (ab1791), MCM2 (ab4461); Suds3 (ab3740) 
Santa Cruz:  Cdc45 (sc-20685), Cdc25A (sc-7389), Chk1 (sc-8408), Cyclin B1 (sc-
245), Cdc25C (sc-327), Cdc25B (sc-65504), p21 (sc-6246),  Cdc45 (sc-20685), 
Cdc25A (sc-7389), Chk1 (sc-8408); RhoA (sc-418); anti-goat IgG-HRP (sc-2020) 
Sigma: (PC10), β-actin (A1978), Cyclin A (C7410), Anti-Flag M2 (F1804), β-actin 
(A1978), Cyclin A (C7410), Flag (F3165); Oct4 (Chemicon, AB3209), and Millipore, 
Nestin (Ab353), H3S10P (Millipore 09-797). Wee1 (kindly provided by T. Lorca, CRBM 
Montpellier).  
Mouse Dub3 polyclonal antibodies were raised by immunizing rabbits with a 
synthetic peptide (NH2-MSPGQLCSQGGR-COOH) designed from mouse Dub3 C-
terminus, coupled to keyhole limpet hemocyanin (KLH). Antibodies were purified by 
coupling the Dub3 peptide on HiTrap NHS-activated HP columns (GE Healthcare). 
 
Chromatin immunoprecipitation 
Cells were lysed in ice-cold lysis buffer (50 mM Tris-HCl pH 7.4, 100 mM NaCl, 50 mM NaF, 
5 mM EDTA, 40 mM β-glycero-phosphate, 1% SDS, 1% Triton X-100 and protease 
inhibitors) for 30 min on ice. Immuoprecipitation was performed by adding 5 µg Esrrb (Sigma 
SAB2100715), Sox2 (Bethyl A301-739) or control antibodies (Peprotech 500-P00) to lysates 
and incubation with rotation overnight at 4 °C. BSA and salmon sperm-blocked Protein A-
Sepharose (Amersham) beads were added to the lysate. 
 
Luciferase assay 
ES cells were transfected with following reporter constructs, pG13-luciferase, p21-
luciferase and p21-ΔREp53-luc (kindly provided by J. Basbous, IGH, Montpellier). A 
Renilla luciferase plasmid was cotransfected as an internal control. Cells were 
harvested 24 hours after transfection and mock or UV-irradiated. Six hours following 
UV-induced DNA damage, cells were harvested and the luciferase activities of the 
cell lysates were measured using the Dual-luciferase Reporter Assay system 
(Promega). The proximal promoter of 1kb upstream ATG start codon was inserted 
into pGL4.10 plasmid. Three mutations of the Esrrb consensus binding site 
(TCAAGGTCA) were introduced by PCR to generate a mutated binding site 
(TCATTTTCA). All constructs were sequence verified. 
 
Immunofluorescence microscopy 
For Nestin, Oct4 and active caspase 3 staining staining, cells were fixed in 4% 
paraformaldehyde and permeabilized with 0,1% Triton X-100. After fixation, cells 
were blocked in 3% BSA PBS-Tween and incubated overnight with antibody. The 
slides were mounted using Prolong Gold with DAPI (Invitrogen). For determination of 
the cellular localisation of Dub3, mouse ES cells were transfected with pcDNA-GFP-
Dub3 and directly fixed. All slides were analysed using a Leica DM6000 
epifluorescence microscope. Images were acquired using a Coolsnap HQ CCD 
camera (Photometrics) and the metamorph software (Molecular Devices). 
 
Subcellular fractionation experiments 
Chromatin-enriched and soluble fractions were prepared using CSK-extraction 
procedure. Briefly, pelleted cells were lysed in CSK buffer (10 mM PIPES pH 6.8, 100 
mM NaCl, 300 mM sucrose, 1 mM EGTA, 1 mM MgCl2, 0.5 mM DTT, 1 mM ATP, 
0.2% Triton X-100 and protease inhibitors) for 10 min on ice. After centrifugation at 
3000 rpm for 3 min at 4 °C, the supernatant (Triton-soluble fraction) was recovered 
and the pellet (Triton-insoluble fraction) was resuspended in CSK buffer and 
incubated for 10 min on ice. After centrifugation, the pellet (chromatin-enriched 
fraction) was resuspended in Laemmli Buffer. Equivalent amount of soluble and 
chromatin fractions were analyzed by immunoblotting. 
 
Statistical analysis 
Two-way ANOVA or Student t-test were used to evaluate differences between groups 
using Prism software (GraphPad Software). P < 0.05 was considered significant and 
indicated with *, P < 0.001 was indicated with **. 
 
  
